Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

NCT00104013 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1455
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi